{"id": "1357065488547917825", "creation": 1612384600.0, "user_id": "1050496287517360128", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "RT RedHillBio: Variants challenge #covid19 control new ways needed to get promising treatments to clinician, writes $RDHL CEO Dror Ben-Asher @FT calls by Sir Stephen Holgate &amp; @anjahuja for dual #vaccine #medicine strategy https://t.co/YGrTtKeZGQ (paid) @NYTimes @carlzimmer @WS\u2026", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#MEDICINE"]}